Publicacións nas que colabora con J. Ignasi Esteban (9)

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2017

  1. Sofosbuvir and daclatasvir in mono-and HIV-coinfected patients with recurrent hepatitis C After liver transplant

    Annals of Hepatology, Vol. 16, Núm. 1, pp. 86-93

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Doubtful role of IL28B polymorphism in occult Hepatitis B infection

    Intervirology, Vol. 58, Núm. 3, pp. 160-165

2014

  1. Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1

    Journal of Viral Hepatitis, Vol. 21, Núm. 10, pp. e118-e128

  2. Outcome of early vs. Deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients

    Annals of Hepatology, Vol. 13, Núm. 2, pp. 219-230

2012

  1. IL28B genetic variation and hepatitis C virus-specific CD4+ T-cell responses in anti-HCV-positive blood donors

    Journal of Viral Hepatitis, Vol. 19, Núm. 12, pp. 867-871

  2. Reversal of nonstructural protein 3-specific CD4 + T cell dysfunction in patients with persistent hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 19, Núm. 4, pp. 283-294

  3. Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients

    Transplantation, Vol. 93, Núm. 4, pp. 450-453